Network Bio
PrivateLast Round
Seed
Aug 19, 2026
Est. Valuation
$170M
Total Funding Raised
$67M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Network Bio is a healthcare technology company that provides a clinical and molecular data library to facilitate precision medicine through the creation of research-grade data assets in concert with healthcare institutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Drug Discovery, Data Warehousing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Network Bio Comparables
Compare Network Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aster Insights | 79% | |
| Flat Iron | 79% | |
| Lifebit | 77% |
Network Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 19, 2026 | ||||
| Seed | Feb 26, 2025 |
Network Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Seed |
| Breyer Capital | Seed |
| Fundomo | Seed |
| Thiel Capital | Seed |
| JSL Health Capital | Seed |
| Founders Fund | Seed |
| ARTIS Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 19, 2026
Raised $50M with participation from Founders Fund and S32.
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
Network is developing bio-native AI architecture.
- partners_withAug 25, 2026
Network partnered with CU Anschutz on Aug 25th '26.
- partners_withAug 25, 2026
Network partnered with Mass General Brigham Incorporated on Aug 25th '26.
- partners_withAug 25, 2026
Network partnered with Upenn on Aug 25th '26.
- is_developingAug 19, 2026
Network is developing cell-free RNA foundation model on Aug 19th '26.
Network Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Network Bio's valuation, stock price, and market status.
Is Network Bio a public or private company?
Network Bio is a private company.
What is the current stock price of Network Bio?
Network Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Network Bio worth (valuation)?
Network Bio's valuation is estimated at $170.0M based on funding round data.
Can I buy Network Bio stock?
Network Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Network Bio's last funding round?
Network Bio's most recent funding round was Seed on February 26, 2025.
Who are the main investors in Network Bio?
Key investors in Network Bio include Breyer Capital, Fundomo, Thiel Capital, JSL Health Capital, Founders Fund.
Will Network Bio IPO soon?
No public IPO plans have been announced for Network Bio.
How can I track Network Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Network Bio's secondary market activity and sign up for updates.